Prevalence and treatment of anti-NMDA receptor encephalitis - Authors' reply

The Lancet Neurology

Volumn 12, Issue 5, 2013, Pages 425-426

  Titulaer, Maarten J ^a,b   Kayser, Matthew S ^a   Dalmau, Josep ^a,b,c  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF BARCELONA   (Spain)

^c INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY; NR1 RECEPTOR ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIBODY; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANTI N METHYL D ASPARTATE RECEPTOR ENCEPHALITIS; HUMAN; LETTER; PRIORITY JOURNAL; BLOOD; CEREBROSPINAL FLUID; FEMALE; IMMUNOLOGY; IMMUNOTHERAPY; MALE; METHODOLOGY; NOTE;

ANTI-N-METHYL-D-ASPARTATE RECEPTOR ENCEPHALITIS; AUTOANTIBODIES; FEMALE; HUMANS; IMMUNOTHERAPY; MALE; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84876477707     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(13)70072-3     Document Type: Letter

References (13)

1. Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008, 7:1091-1098.
2. Masdeu JC, Gonzalez-Pinto A, Matute C, et al. Serum IgG antibodies against the NR1 subunit of the NMDA receptor not detected in schizophrenia. Am J Psychiatry 2012, 169:1120-1121.
3. Pruss H, Finke C, Holtje M, et al. N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis. Ann Neurol 2012, 72:902-911.
4. Armangue T, Titulaer MJ, Malaga I, et al. Pediatric Anti-N-methyl-D-Aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients. J Pediatr 2012, published online Nov 16. 10.1016/j.jpeds.2012.10.011.
5. Steiner J, Walter M, Glanz W, et al. Increased prevalence of diverse N-Methyl-D-Aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N -Methyl-D-Aspartate glutamate receptor encephalitis. JAMA Psychiatry 2013, 70:271-278.
6. Pruss H, Holtje M, Maier N, et al. IgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment. Neurology 2012, 78:1743-1753.
7. Zandi MS, Irani SR, Lang B, et al. Disease-relevant autoantibodies in first episode schizophrenia. J Neurol 2011, 258:686-688.
8. Rhoads J, Guirgis H, McKnight C, Duchemin AM Lack of anti-NMDA receptor autoantibodies in the serum of subjects with schizophrenia. Schizophr Res 2011, 129:213-214.
9. Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013, 12:157-165.
10. Martinez-Hernandez E, Horvath J, Shiloh-Malawsky Y, Sangha N, Martinez-Lage M, Dalmau J Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis. Neurology 2011, 77:589-593.
11. Pruss H, Dalmau J, Harms L, et al. Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin. Neurology 2010, 75:1735-1739.
12. Leypoldt F, Gelderblom M, Schottle D, Hoffmann S, Wandinger KP Recovery from severe frontotemporal dysfunction at 3 years after N-methyl-d-aspartic acid (NMDA) receptor antibody encephalitis. J Clin Neurosci 2013, published online Jan 10. 10.1016/j.jocn.2012.03.036.
13. Panzer JA, Lynch DR Neuroimmunology: treatment of anti-NMDA receptor encephalitis-time to be bold?. Nat Rev Neurol 2013, published online March 5. 10.1038/nrneurol.2013.31.